L-asparaginase is commonly used in the treatment of T-ALL exploiting the inability of the blasts to synthesize de novo asparagine due to the lack of asparagine synthetase (ASNS)27,28. This evidence concerns the gene ASPG and acute lymphoblastic leukemia.